Vimarsana
Biggest News Aggregation in the World

Page 9 - Nasdaq Coll News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Coll. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Coll Today - Breaking & Trending Today

Collegium Pharmaceutical (COLL) to Release Earnings on Thursday - Vimarsana News

Collegium Pharmaceutical (COLL) to Release Earnings on Thursday

Collegium Pharmaceutical (NASDAQ:COLL – Get Rating) is set to release its earnings data after the market closes on Thursday, May 4th. Analysts expect Collegium Pharmaceutical to post earnings of $1.26 per share for the quarter. Collegium Pharmaceutical has set its FY 2023 guidance at EPS.Persons interested in listening to the company’s earnings conference call can […]

Source: wkrb13.com
South Dakota Investment Council Purchases 7,725 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Vimarsana News

South Dakota Investment Council Purchases 7,725 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

South Dakota Investment Council grew its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) by 2.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 281,572 shares of the specialty pharmaceutical company’s stock after acquiring an additional 7,725 shares during […]

Collegium Pharmaceutical (NASDAQ:COLL) PT Lowered to $35.00 at Piper Sandler - Vimarsana News

Collegium Pharmaceutical (NASDAQ:COLL) PT Lowered to $35.00 at Piper Sandler

Collegium Pharmaceutical (NASDAQ:COLL – Get Rating) had its price target lowered by Piper Sandler from $37.00 to $35.00 in a research report released on Tuesday, The Fly reports. Other research analysts also recently issued research reports about the stock. StockNews.com began coverage on shares of Collegium Pharmaceutical in a research report on Thursday, March 16th. […]

Collegium Pharmaceutical (NASDAQ:COLL) Given New $35.00 Price Target at Piper Sandler - Vimarsana News

Collegium Pharmaceutical (NASDAQ:COLL) Given New $35.00 Price Target at Piper Sandler

Collegium Pharmaceutical (NASDAQ:COLL – Get Rating) had its price objective cut by equities researchers at Piper Sandler from $37.00 to $35.00 in a research note issued to investors on Tuesday, The Fly reports. Piper Sandler’s price objective suggests a potential upside of 49.57% from the stock’s current price. A number of other equities research analysts […]

Source: wkrb13.com
Mesirow Institutional Investment Management Inc. Sells 89,831 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Vimarsana News

Mesirow Institutional Investment Management Inc. Sells 89,831 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Mesirow Institutional Investment Management Inc. reduced its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) by 23.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 290,534 shares of the specialty pharmaceutical company’s stock after selling 89,831 shares during the period. Mesirow […]